eli lilly glp-1 mounjaro endowment to seek approval of new weight-loss drug this year FDA approves Eli Lilly's new

doi: 10.1038/s41586-021-03729-3

[13] Microvascular effects (retinopathy) [edit] Initial trials noted an increase in complications related to diabetic retinopathy

R., Ruan, Y

About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data compiled by Real Chemistry, a health analytics firm

ZhangQDelessaCTBakhtiARColldnMDruckerGJDet alThe glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling

Further reading on observed adverse signal profiles from the investigational phase 2 programme is available in the Retatrutide Side Effects: Detailed Guide with Clinical Trial Insights 2026 article, which summarises published tolerability data for research planning purposes